• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2026
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2026
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    The agency issued an updated label for the antidepressant aripiprazole, the active ingredient in Abilify, Abilify Maintena and Aristada. (Bloomberg/Daniel Acker)
    Healthcare

    FDA: Antidepressant can cause gambling, binge eating, shopping and sex

    Robert King -
    May 3, 2016 9:22 pm
    0
    Editorial cartoon: Rest in opioid
    Editorial cartoons

    Editorial cartoon: Rest in opioid

    Washington Examiner -
    May 3, 2016 7:00 pm
    0
    Shkreli is charged with using an investment fund to prop up the earnings for the Retrophin. (AP Photo/Susan Walsh, File)
    Healthcare

    Shkreli may face more charges

    Robert King -
    May 3, 2016 6:26 pm
    0
    Insurers still have ways of imposing undue costs and burdens on customers — particularly those suffering from chronic and serious health conditions. (iStock photo)
    Healthcare

    It’s time to end all types of healthcare discrimination

    Carl Schmid -
    May 2, 2016 4:03 am
    0
    Sens. Susan Collins, R-Maine, and Claire McCaskill, D-Mo., filed legislation in March calling for the agency to change the way it prioritizes generic drug applications. (AP Photo/Manuel Balce Ceneta)
    Healthcare

    FDA takes aim at high-priced generics

    Robert King -
    May 2, 2016 4:01 am
    0
    On Thursday, the FDA authorized Quest Diagnostics to offer the first commercial test for the Zika virus in the United States. (AP Photo/Arnulfo Franco, File)
    Healthcare

    FDA approves Zika test

    Robert King -
    April 29, 2016 6:53 pm
    0
    Salary of $67 million will be
    Healthcare

    Senator: New Valeant CEO’s pay ‘tone deaf’

    Robert King -
    April 27, 2016 11:24 pm
    0
    Healthcare

    Senator: Drugmaker’s high prices not isolated

    Robert King -
    April 27, 2016 9:54 pm
    0
    Healthcare

    Senators not buying drugmaker’s contrition

    Robert King -
    April 27, 2016 8:38 pm
    0
    The House provision would allow a pharmacist to make a small amount of a drug in preparation for getting a prescription from a doctor, a practice called
    Healthcare

    Big Pharma duels with pharmacies in funding fight

    Robert King -
    April 27, 2016 4:01 am
    0
    1...122123124...156Page 123 of 156
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.